Thursday | 26 April 2018

09.00 Welcome Session
Manuel Sobrinho-Simões, i3S/ Ipatimup & Mário Barbosa, i3S

SESSION 1: THE BASIS FOR IMMUNO-ONCOLOGY

Chairs: Rui Henrique and José Carlos Machado

9.15-9.45 Immunomodulation at the Tumor Microenvironment: basis and challenges
Maria José Oliveira, i3S / INEB

9.45-10.15 Neoantigen landscape dynamics during T cell therapy
Els Verdegaal, Leiden University Medical Centre

10.15-10.45 Coffee-break

10.45-11.15 Combined analysis of antigen presentation and T cell recognition reveals restricted immune responses in melanoma
Shelly Kalaora, Weizmann Institute of Science

11.15-11:45 Selected talk | Different TLR signalling pathways induce macrophages or neutrophils with anti-tumour functions in vivo
Karine Serre, iMM – Instituto de Medicina Molecular – João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa

12.00-13.00 Lunch

13:00-15:00 Speed Talks
Chairs: Ana Sofia Ribeiro and Bruno Pereira

SESSION 2: RECENT ADVANCES IN IMMUNE CHECKPOINT BLOCKADE

Chairs: Paulo Cortes and André Albergaria

15.00-15.30 Neo-adjuvant therapy as pathway toward personalised immunotherapy
Christian Blank, Netherlands Cancer Institute

15.30-16.00 New strategies with immunotherapy for second-line non-small cell lung cancer
Manuel Cobo Dols, Hospital Regional Universitario Carlos Haya

16.00-16.30 Coffee-break

16.30-17.00  Biomarkers for Immunotherapy: the dark side
Fernando Schmitt, FMUP, i3S / Ipatimup

20.00 Meeting Dinner – Casa da Música


Friday | 27 April 2018

SESSION 3: IMMUNE CELL THERAPIES

Chairs: Nuno Alves and Júlio Oliveira

9.00-9.30 Delta One T cells: development of a novel immune cell therapy for cancer
Bruno Silva Santos, IMM

9.30-10.00 Expanding the T-cell therapy battlefield
Sébastien Wälchli, Oslo University Hospital-Radiumhospitalet

10.00-10.30 Coffee-break

10.30-11.00 Dendritic cell-based vaccination against cancer
Jolanda de Vries, Radboud Institute for Molecular Life Sciences (RIMLS); Radboud University Nijmegen Medical Centre

11.00-11.30 Selected talk | CD7-Edited T Cells Expressing a CD7-Specific Chimeric Antigen Receptor for the Therapy of Acute Myeloid Leukemia
Diogo Silva, Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital, Houston Methodist Hospital; Department of Bioengineering and Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa

11.30-12.45 Speed talks
Chairs: Joana Figueiredo and João Vinagre

12.45-13.30 Lunch 

13.30-14.30 Poster viewing

SESSION 4: NOVEL APPROACHES IN IMMUNO-ONCOLOGY

Chairs: Jorge Lima and José Dinis Silva

14.30-15.00 Provoke, Unleash, Prevent
Ezogelin Oflazoglu-Gruyters, MedImmune

15.00-15.30 Targeting natural immune regulation in oncology
Jocelyne Demengeot, Instituto Gulbenkian de Ciência

15.30-16.00 Redaporfin PDT combined with Anti-PD-1 treatment in melanoma mouse model: alterations in T-cell subsets
Carlos Palmeira, IPO-Porto

Adjourn